ABSTRACT
Purpose The COVID-19 pandemic and the resulting social distancing and lockdown measures are having a substantial impact on daily life and medical management of people with breast cancer. We evaluated to what extent these changes have affected quality of life and physical, and psychosocial wellbeing of people (being) treated for breast cancer.
Methods This study was conducted within the prospective Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaluation (UMBRELLA). Shortly after the implementation of COVID-19 measures, extra questionnaires were sent to 1595 cohort participants, including standard UMBRELLA quality of life (EORTC) questionnaires. Patient-reported outcomes (PROs) were compared to the most recent PROs collected within UMBRELLA before COVID-19. The impact of COVID-19 on PROs was evaluated using mixed models analysis.
Results In total, 1051 patients (66%) completed the questionnaires. One third (n = 327, 31%) reported a higher threshold to contact their general practitioner due to COVID-19. A significant deterioration in emotional functioning was observed (82·6 to 77·9, p < 0.001) and 505 (48%, 95% CI 45-51) patients reported moderate to severe loneliness. Small significant improvements were observed in QoL, physical-, social- and role functioning scores. In the subgroup of 51 patients under active treatment, there was a strong deterioration in social functioning (69·8 to 5·0, p = 0·03).
Conclusion Due to COVID-19, patients (being) treated for breast cancer are less likely to contact physicians, and experience a deterioration in emotional functioning. Patients undergoing active treatment report a strong drop in social functioning. One in two patients reports (severe) loneliness. Online applications facilitating peer contact and e-mental health interventions could support mental health and social interaction times of total lockdown or social distancing.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02839863
Funding Statement
The authors received no financial support for the research (including study design; data collection, analysis, interpretation of data; and writing of the report), authorship, and/ or (the decision to submit the article for) publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Medical Ethics Committee of the UMCU (NL52651.041.15, METC 15/165)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Role of the funding source The authors received no financial support for the research (including study design; data collection, analysis, interpretation of data; and writing of the report), authorship, and/ or (the decision to submit the article for) publication.
Disclosure of relationships and activities The authors have no conflicts of interest to disclose.
Data Availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
ABBREVIATIONS
- BMI
- Body Mass Index
- CF
- Cognitive functioning (EORTC-QLQ30 subdomain)
- CI
- 95% Confidence Interval
- COVID-19
- COronaVIrus Disease 2019
- DCIS
- Ductal carcinoma in situ
- EF
- Emotional functioning (EORTC-QLQ30 subdomain)
- EORTC
- European Organization for Research and Treatment of Cancer
- HADS
- Hospital Anxiety and Depression Scale
- IQR
- Interquartile range
- MD
- Mean Difference
- METC
- Medical Ethics Research Committee (Dutch: Medisch Ethische Toetsingscommissie)
- n
- number
- NKR
- Netherlands Cancer Registry
- PF
- Physical functioning (EORTC-QLQ30 subdomain)
- PRO(s)
- Patient reported outcome(s)
- QoL
- Quality of Life
- RF
- Role functioning (EORTC-QLQ30 subdomain)
- SD
- Standard deviation
- SF
- Social functioning (EORTC-QLQ30 subdomain)
- SPSS
- Statistical Package for Social Sciences
- STROBE
- STrengthening the Reporting of OBservational studies in Epidemiology
- UMBRELLA
- Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaluation
- UMCU
- University Medical Center Utrecht
- WHO
- World Health Organization
